114 related articles for article (PubMed ID: 9714066)
1. Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells.
Lavie Y; Zhang ZC; Cao HT; Han TY; Jones RC; Liu YY; Jarman M; Hardcastle IR; Giuliano AE; Cabot MC
Int J Cancer; 1998 Sep; 77(6):928-32. PubMed ID: 9714066
[TBL] [Abstract][Full Text] [Related]
2. Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.
Soh JW; Lee YS; Weinstein IB
J Exp Ther Oncol; 2003; 3(3):115-26. PubMed ID: 14641818
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells.
Gundimeda U; Chen ZH; Gopalakrishna R
J Biol Chem; 1996 Jun; 271(23):13504-14. PubMed ID: 8662863
[TBL] [Abstract][Full Text] [Related]
4. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.
Tonetti DA; Chisamore MJ; Grdina W; Schurz H; Jordan VC
Br J Cancer; 2000 Sep; 83(6):782-91. PubMed ID: 10952784
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation.
Cabot MC; Zhang Z; Cao H; Lavie Y; Giuliano AE; Han TY; Jones RC
Int J Cancer; 1997 Mar; 70(5):567-74. PubMed ID: 9052757
[TBL] [Abstract][Full Text] [Related]
6. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells.
Gonzalez-Villasana V; Gutiérrez-Puente Y; Tari AM
Oncol Rep; 2013 Sep; 30(3):1506-10. PubMed ID: 23783392
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21(waf1/cip1).
Rohlff C; Blagosklonny MV; Kyle E; Kesari A; Kim IY; Zelner DJ; Hakim F; Trepel J; Bergan RC
Prostate; 1998 Sep; 37(1):51-9. PubMed ID: 9721069
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen.
Cheng AL; Chuang SE; Fine RL; Yeh KH; Liao CM; Lay JD; Chen DS
Biochem Pharmacol; 1998 Feb; 55(4):523-31. PubMed ID: 9514088
[TBL] [Abstract][Full Text] [Related]
12. The tamoxifen-induced suppression of telomerase activity in the human hepatoblastoma cell line HepG2: a result of post-translational regulation.
Brandt S; Heller H; Schuster KD; Grote J
J Cancer Res Clin Oncol; 2005 Feb; 131(2):120-8. PubMed ID: 15503139
[TBL] [Abstract][Full Text] [Related]
13. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
El Etreby MF; Liang Y; Wrenn RW; Schoenlein PV
Breast Cancer Res Treat; 1998 Sep; 51(2):149-68. PubMed ID: 9879777
[TBL] [Abstract][Full Text] [Related]
14. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
Fan P; Wang J; Santen RJ; Yue W
Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.
Ping P; Zhang J; Qiu Y; Tang XL; Manchikalapudi S; Cao X; Bolli R
Circ Res; 1997 Sep; 81(3):404-14. PubMed ID: 9285643
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin.
Greco S; Storelli C; Marsigliante S
J Endocrinol; 2006 Jan; 188(1):79-89. PubMed ID: 16394177
[TBL] [Abstract][Full Text] [Related]
18. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C epsilon translocation and phosphorylation by cis-diamminedichloroplatinum(II) (CDDP): potential role in CDDP-mediated cytotoxicity.
Ohmori T; Arteaga CL
Cell Growth Differ; 1998 Apr; 9(4):345-53. PubMed ID: 9563854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
